cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Becton Dickinson And Company
77 own
20 watching
Current Price
$234.4
$-0.46
(-0.2%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
67,824.04M
52-Week High
52-Week High
287.32001
52-Week Low
52-Week Low
229.39999
Average Volume
Average Volume
0.98M
Dividend Yield
Dividend Yield
0.013623
P/E Ratio
P/E Ratio
37.5288
iconMarket Capitalization67,824.04M
icon52-Week High287.32001
icon52-Week Low229.39999
iconAverage Volume0.98M
iconDividend Yield0.013623
iconP/E Ratio37.5288
What does the Becton Dickinson And Company do?
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. It operates in two segments, BD Medical and BD Life Sciences. The BD Medical segment offers syringes, pen needles, and IV sets for diabetes; needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; regional anesthesia needles and trays; sharps disposal containers; closed-system transfer devices; skin antiseptic products; surgical and laproscopic instrumentations; intravenous medication safety and infusion therapy delivery, and automated medication dispensing and supply management systems; and prefillable drug delivery systems. The BD Life Sciences segment provides integrated systems for specimen collection; safety-engineered blood collection, automated blood culturing and tuberculosis culturing, and microorganism identification and drug susceptibility systems; molecular testing systems for infectious diseases and women's health; liquid-based cytology systems for cervical cancer screening; rapid diagnostic assays; microbiology laboratory automation, and plated media products; fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; molecular indexing and next-generation sequencing sample preparation for genomics research; clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers; and cell culture media supplements for biopharmaceutical manufacturing. The company markets its products through independent distribution channels and sales representatives to healthcare institutions, life science researchers, clinical laboratories, pharmaceutical industry, and general public. Becton, Dickinson and Company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
Read More
How much money does Becton Dickinson And Company make?
News & Events about Becton Dickinson And Company.
PR Newswire
1 year ago
BD Recognized by DiversityInc as a Top U.S. Company for Diversity in 2023 List BD Recognized by DiversityInc as a Top U.S. Company for Diversity in 2023 List PR Newswire FRANKLIN LAKES, N.J., May 3, 2023 FRANKLIN LAKES, N.J., May 3, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE...
PR Newswire
1 year ago
BD Recognized by Forbes as a Best Employer for Diversity in 2023 List BD Recognized by Forbes as a Best Employer for Diversity in 2023 List PR Newswire FRANKLIN LAKES, N.J., April 25, 2023 Accolade Represents Positive Perceptions from Employees and Progress in Advancing ESG Strategy FRANKLIN LAKES...
Zolmax
1 year ago
New Mexico Educational Retirement Board cut its holdings in Becton, Dickinson and Company (NYSE:BDX Get Rating) by 6.2% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 13,666 shares of the medical instruments suppliers stock after selling 900 ...
Zolmax
1 year ago
Sompo Asset Management Co. Ltd. grew its stake in Becton, Dickinson and Company (NYSE:BDX Get Rating) by 10.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,010 shares of the medical ...
Ticker Report
1 year ago
Destiny Wealth Partners LLC raised its holdings in shares of Becton, Dickinson and Company (NYSE:BDX Get Rating) by 6.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,270 shares of the medical ...
Frequently Asked Questions
Frequently Asked Questions
What is Becton Dickinson And Company share price today?
plus_minus_icon
Can Indians buy Becton Dickinson And Company shares?
plus_minus_icon
How can I buy Becton Dickinson And Company shares from India?
plus_minus_icon
Can Fractional shares of Becton Dickinson And Company be purchased?
plus_minus_icon
What are the documents required to start investing in Becton Dickinson And Company stocks?
plus_minus_icon
What is today’s traded volume of Becton Dickinson And Company?
plus_minus_icon
What is today’s market capitalisation of Becton Dickinson And Company?
plus_minus_icon
What is the 52-Week High and Low Range of Becton Dickinson And Company?
plus_minus_icon
What percentage is Becton Dickinson And Company down from its 52-Week High?
plus_minus_icon
What percentage is Becton Dickinson And Company up from its 52-Week Low?
plus_minus_icon
Current Price
$234.4
$-0.46
(-0.2%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00